clinicaltrialvanguard

Arcus Biosciences reports $694M cash for pipeline advancement through pivotal trials

Arcus Biosciences has $694M in cash to advance its pipeline through pivotal trials, including the Phase 3 PRISM-1 study of ...
clinicaltrialvanguard

YPrime Names Greg Wellbrock Chief Data and AI Officer

YPrime names Greg Wellbrock Chief Data and AI Officer to lead unified data and AI strategy across its clinical trial ...
clinicaltrialvanguard

FDA Clears Fresenius multiFiltratePRO for Regional Citrate Anticoagulation

FDA clears Fresenius multiFiltratePRO for regional citrate anticoagulation in acute kidney injury, with integrated pumps and ...
clinicaltrialvanguard

Fifth Circuit Vacates Class Certification in Filana Therapeutics Securities Case

Fifth Circuit vacates class certification in Filana Therapeutics securities case, removing litigation overhang as company ...
clinicaltrialvanguard

Why Pharma’s AI Future Depends on Standardization First

Veeva launches flat-rate AI pricing and Falcon agentic tools for clinical trials. Explore simplified pricing and platform ...